Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Dropped 45.8% in First Three Quarters of 2023

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 760.4 million yuan in the first three quarters of 2023, down 45.8% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, down 0.4% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 369.2 million yuan in total liabilities, with a liability-to-asset ratio of 5.1%.